Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03NUC
|
|||
| Former ID |
DNC013799
|
|||
| Drug Name |
Cyclopentylcarbamic Acid Biphenyl-3-yl Ester
|
|||
| Synonyms |
CHEMBL448753; Cyclopentylcarbamic Acid Biphenyl-3-yl Ester; BDBM50256913; Cyclopentyl-carbamic acid biphenyl-3-yl ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H19NO2
|
|||
| Canonical SMILES |
C1CCC(C1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C18H19NO2/c20-18(19-16-10-4-5-11-16)21-17-12-6-9-15(13-17)14-7-2-1-3-8-14/h1-3,6-9,12-13,16H,4-5,10-11H2,(H,19,20)
|
|||
| InChIKey |
ASBRBCNHGJSXLE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.